Unibest
← Back to patent-cliff list

CAS 2387-48-6

2,4-Diamino-6-hydroxy-5-nitrosopyrimidine

Codes: Folic Acid-060

Application context (from source-drug indications)

Essential hypertensionEnalapril Maleate/Folic AcidMegaloblastic anaemiaFolic AcidFolate deficiencyFolic AcidNeural tube defectFolic AcidAnaemiaFolic AcidHot flushesFolic AcidHyperhomocysteinaemiaFolic Acid

Source drugs (routes using this intermediate)

DrugTierExpiry
Enalapril Maleate/Folic AcidTier C — Watch / trade-
Folic AcidTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Enalapril Maleate/Folic AcidOptimised routesteps: 7total yield: 18.76g(Folic Acid (Free))
Enalapril Maleate/Folic AcidProcess routesteps: 1total yield: 1898.52g(Folic Acid (Free))
(2S)-[(4-Nitrobenzoyl)amino]pentanedioic acid→2,4-Diamino-6-hydroxy-5-nitrosopyrimidine→1,1,1-Trichloropropan-2-one
Folic AcidOptimised routesteps: 7total yield: 18.76g(Folic Acid (Free))
Folic AcidProcess routesteps: 1total yield: 1898.52g(Folic Acid (Free))
(2S)-[(4-Nitrobenzoyl)amino]pentanedioic acid→2,4-Diamino-6-hydroxy-5-nitrosopyrimidine→1,1,1-Trichloropropan-2-one

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.